CTI BIOPHARMA CORP (22) | Human Resources (9)
Browse by Subcategory
Recent Contracts
-
Amendment to Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022
(Filed With SEC on March 4, 2022)
-
CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan
(Filed With SEC on June 7, 2021)
-
CTI BioPharma Corp. Director Compensation Policy
(Filed With SEC on May 6, 2021)
-
Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of January 6, 2015
(Filed With SEC on March 4, 2022)
-
CTI BioPharma Corp. 2017 Equity Incentive Plan Stock Option Agreement
(Filed With SEC on November 10, 2020)
-
Director Compensation Policy
(Filed With SEC on March 13, 2020)
-
CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan
(Filed With SEC on May 17, 2019)
-
Director Compensation Policy
(Filed With SEC on May 2, 2019)
-
CTI BioPharma Corp. Executive Incentive Compensation Plan
(Filed With SEC on March 13, 2019)